In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, ...
Immunovant remains on track for the first of the two batoclimab Phase 3 thyroid eye disease (TED) studies to read out before the end of calendar year 2025. However, due to evolving competitive ...
NEW YORK, Nov 5 (Reuters) - The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, was no more effective than a placebo, a ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to overhaul its approach to therapies for rare diseases. In a position paper, the agency highlighted that rare ...
The first mRNA therapeutics company was founded in 1997, and rather than targeting infectious disease, it had its sights set on cancer treatment. Its approach ultimately hasn't panned out in human ...
A plant compound found in apples, figs and guava could one day replace antibiotics in treating gum disease, according to a new study. Scientists from São Paulo State University's Araraquara School of ...
University of Saskatchewan scientists developed the lung tissue model to provide a better environment for studying medicines and diseases. Man gropes, attacks store's customers, then female shopper ...
Biomedical startups are taking aim at a deadly lung condition that has long lacked innovative treatments. Chronic obstructive pulmonary disease, caused by smoking and air pollution, hinders breathing ...
This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. Alzheimer’s disease has proved to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback